The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Parkinson’s Disease Therapeutics Pipeline Program, 2025CT600 as a Neuroprotective Peptide Therapeutic for Parkinson’s Disease
Study Rationale: Excess CDK5 protein kinase activity in the brain caused by the binding of CDK5 with another protein called P25 has been connected to Parkinson's disease. The CDK5-P25 interaction can...
-
Parkinson’s Disease Therapeutics Pipeline Program, 2025Neuroprotective Therapy for PD Using Stabilizers of the LRRK2:14-3-3 Interaction, Supplement
Study Rationale: Our previous work shows that regulation of the phosphorylation of the Parkinson’s disease protein ‘leucine-rich repeat kinase 2’ (LRRK2) is a key mechanism controlling LRRK2...
-
Parkinson’s Disease Therapeutics Pipeline Program, 2025Assessing Pre-clinical Efficacy of Brain-penetrant TRPML1 Agonists to Treat Parkinson’s Disease
Study Rationale: Parkinson’s disease (PD) is characterized by the accumulation of misfolded and aggregated alpha-synuclein inside neurons in the brain. This may either arise from, or be exacerbated by...
-
Parkinson’s Disease Therapeutics Pipeline Program, 2025ACT-02 as a Disease-modifying Therapy for Parkinson’s
Study Rationale: Parkinson’s disease (PD) is a complex neurodegenerative disorder marked by the loss of dopaminergic neurons, however the underlying exact reasons are still not fully understood...
-
Research Grant, 2025Phenotypic and Construct Validity of Pink1-/- in Pre-clinical Models for Pre-clinical Parkinson’s Research
Study Rationale: Parkinson’s disease is a common neurodegenerative disorder that is usually diagnosed in people between 60 and 65 years old, but it likely starts about 20 years earlier. During this...
-
Accelerating Biological Understanding and Therapeutic Translation for PD-Biology, 2025Evaluating Modifiable Risk Factors for Parkinson’s Disease in the Global Burden of Disease Study
Study Rationale: Parkinson’s disease is becoming more and more common over time, but we don’t know why. We will assess how much five key risk factors increase the risk of developing Parkinson’s...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.